138 related articles for article (PubMed ID: 38224931)
21. TFPI2 and NDRG4 gene promoter methylation analysis in peripheral blood mononuclear cells are novel epigenetic noninvasive biomarkers for colorectal cancer diagnosis.
Bagheri H; Mosallaei M; Bagherpour B; Khosravi S; Salehi AR; Salehi R
J Gene Med; 2020 Aug; 22(8):e3189. PubMed ID: 32196834
[TBL] [Abstract][Full Text] [Related]
22. DNA methylation biomarkers in stool for early screening of colorectal cancer.
Chen J; Sun H; Tang W; Zhou L; Xie X; Qu Z; Chen M; Wang S; Yang T; Dai Y; Wang Y; Gao T; Zhou Q; Song Z; Liao M; Liu W
J Cancer; 2019; 10(21):5264-5271. PubMed ID: 31602277
[No Abstract] [Full Text] [Related]
23. Using Comorbidity Pattern Analysis to Detect Reliable Methylated Genes in Colorectal Cancer Verified by Stool DNA Test.
Cheng YC; Wu PH; Chen YJ; Yang CH; Huang JL; Chou YC; Chang PK; Wen CC; Jao SW; Huang HH; Tsai YH; Pai TW
Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680934
[TBL] [Abstract][Full Text] [Related]
24. Detection of Circulating Tumor DNA Methylation in Diagnosis of Colorectal Cancer.
Xu F; Yu S; Han J; Zong M; Tan Q; Zeng X; Fan L
Clin Transl Gastroenterol; 2021 Aug; 12(8):e00386. PubMed ID: 34382948
[TBL] [Abstract][Full Text] [Related]
25. SDC2 and TFPI2 Methylation in Stool Samples as an Integrated Biomarker for Early Detection of Colorectal Cancer.
Zhang W; Yang C; Wang S; Xiang Z; Dou R; Lin Z; Zheng J; Xiong B
Cancer Manag Res; 2021; 13():3601-3617. PubMed ID: 33958894
[TBL] [Abstract][Full Text] [Related]
26. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening.
Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M
Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497
[TBL] [Abstract][Full Text] [Related]
27. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in Colorectal Cancer.
Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
[TBL] [Abstract][Full Text] [Related]
28. Multiple Biomarker-Combined Screening for Colorectal Cancer Based on Bisulfate Conversion-Free Detection of Fecal DNA Methylation.
Liu C; Xu L; Li W; Jie M; Xue W; Yu W
Biomed Res Int; 2021; 2021():1479748. PubMed ID: 34621892
[TBL] [Abstract][Full Text] [Related]
29. Highly sensitive fecal DNA testing of NDRG4 12b methylation is a promising marker for detection of colorectal precancerosis.
Ji X; Sha J; Qian H; Zhang G; He T; Dang Y
J BUON; 2021; 26(4):1239-1245. PubMed ID: 34564976
[TBL] [Abstract][Full Text] [Related]
30. A novel panel of stool-based DNA biomarkers for early screening of colorectal neoplasms in a Chinese population.
Sun M; Liu J; Hu H; Guo P; Shan Z; Yang H; Wang J; Xiao W; Zhou X
J Cancer Res Clin Oncol; 2019 Oct; 145(10):2423-2432. PubMed ID: 31456088
[TBL] [Abstract][Full Text] [Related]
31. Performance of a Novel Blood-Based Early Colorectal Cancer Screening Assay in Remaining Serum after the Blood Biochemical Test.
Chen Y; Wang Z; Zhao G; Sun C; Ma Y; Zhang L; Zheng M; Li H
Dis Markers; 2019; 2019():5232780. PubMed ID: 31089394
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic accuracy of DNA-based SDC2 methylation test in colorectal cancer screening: a meta-analysis.
Wang L; Liu Y; Zhang D; Xiong X; Hao T; Zhong L; Zhao Y
BMC Gastroenterol; 2022 Jun; 22(1):314. PubMed ID: 35754025
[TBL] [Abstract][Full Text] [Related]
33. Colorectal adenoma and cancer detection based on altered methylation pattern of SFRP1, SFRP2, SDC2, and PRIMA1 in plasma samples.
Barták BK; Kalmár A; Péterfia B; Patai ÁV; Galamb O; Valcz G; Spisák S; Wichmann B; Nagy ZB; Tóth K; Tulassay Z; Igaz P; Molnár B
Epigenetics; 2017 Sep; 12(9):751-763. PubMed ID: 28753106
[TBL] [Abstract][Full Text] [Related]
34. Value of faecal exfoliated cells in colorectal tumour screening using SDC2 methylation test.
Liu YM; Peng L; Chen C; Zhou P; Cheng B; Luo Y; Zhou MF; Xuan SX; Lin JD; Yin WG
Ann Med; 2023; 55(2):2261111. PubMed ID: 37783044
[TBL] [Abstract][Full Text] [Related]
35. The Application Value of Syndecan-2 Gene Methylation for Colorectal Cancer Diagnosis: A Clinical Study and Meta-Analyses.
Yue C; Zhang Y; Wang Y; Zhang Z; Zhang M; Wang H; Chen W; Shang Z; Xin Y; Zhang X; Zhang Y
Front Med (Lausanne); 2022; 9():753545. PubMed ID: 35372441
[TBL] [Abstract][Full Text] [Related]
36. A simplified multiplex methylated DNA testing for early detection of colorectal cancer in stool DNA.
Dai Y; Zhao G; Yang J; Zhou X; Xiong S; Lu X; Gao L; Wu J; Xu Z; Fei S; Zheng M; Xu H
BMC Gastroenterol; 2022 Oct; 22(1):428. PubMed ID: 36203138
[TBL] [Abstract][Full Text] [Related]
37. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients.
Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH
Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217
[TBL] [Abstract][Full Text] [Related]
38. Detection of colorectal cancer in urine using DNA methylation analysis.
Bach S; Paulis I; Sluiter NR; Tibbesma M; Martin I; van de Wiel MA; Tuynman JB; Bahce I; Kazemier G; Steenbergen RDM
Sci Rep; 2021 Jan; 11(1):2363. PubMed ID: 33504902
[TBL] [Abstract][Full Text] [Related]
39. External quality assessment for detection of methylated Syndecan 2 (
Fan X; Shi C; Wei M; Xiao Y; Wang X
Clin Chem Lab Med; 2022 Sep; 60(10):1570-1576. PubMed ID: 35942951
[TBL] [Abstract][Full Text] [Related]
40. Identification of two methylated fragments of an SDC2 CpG island using a sliding window technique for early detection of colorectal cancer.
Li R; Qu B; Wan K; Lu C; Li T; Zhou F; Lin J
FEBS Open Bio; 2021 Jul; 11(7):1941-1952. PubMed ID: 33955718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
